<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03193879</url>
  </required_header>
  <id_info>
    <org_study_id>2015CB553402</org_study_id>
    <nct_id>NCT03193879</nct_id>
  </id_info>
  <brief_title>Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma</brief_title>
  <official_title>Effects of Particulate Matter on the Lung Function and Acute Exacerbation of COPD and Asthma Patients－－A Multi-center Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xinjiang Autonomous Region People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cangzhou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chengdu sixth People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chengde Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Fengtai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Medical College, Ningbo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Peace Hospital of Changzhi Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Boai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhu Hospital of Chinese Traditional Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Jinzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fujian Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harbin Zhongshan Asthma Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rizhao Hospital of Chinese Traditional Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>3201 hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chengdu Fifth People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First People 's Hospital of Changsha</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing Jiangjin Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Affiliated hospital of Guilin medical university, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangxi People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese People 's Liberation Army Navy Anqing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Inner Mongolia Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yancheng Dafeng People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ShuGuang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of the Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taizhou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Third Affiliated Hospital of Xinjiang Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First People 's Hospital of Kunming</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First People 's Hospital of Yunnan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pingxiang People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northern Jiangsu People 's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Economic Hospital of Xinjiang Uygur Autonomous Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a
      variety of respiratory diseases, including COPD and asthma. This study focus on the effects
      of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China,
      where PM exposure is much heavier than the United States and European countries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a
      variety of respiratory diseases, including COPD and asthma. This study focus on the effects
      of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China,
      where PM exposure is much heavier than the United States and European countries. This study
      is an observational study which lasts 3 years. Primary outcome measures:Change in spirometry
      (FEV1) of COPD, asthma patients and healthy volunteers in response to different exposure
      doses of PM.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Change in spirometry (FEV1) of COPD, asthma patients and healthy volunteers in response to different exposure doses of PM.</measure>
    <time_frame>2 years</time_frame>
    <description>Spirometry will be assessed at baseline and through study completion, an average of 2 years.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in morbidity of acute exacerbation in COPD and asthma patients in response to different exposure doses of PM.</measure>
    <time_frame>2 years</time_frame>
    <description>Patients will be followed up through study completion, an average of 2 years.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pulmonary Function</condition>
  <arm_group>
    <arm_group_label>COPD group</arm_group_label>
    <description>COPD patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthma group</arm_group_label>
    <description>Asthma patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health group</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biological specimens are preserved in serum, plasma, and leukocytes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Clinic-based population
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. COPD patients: clinical manifestation of COPD; post bronchodilator FEV1/FVC&lt;0.70.

          2. Asthma patients: clinical manifestation of asthma; recurrent dyspnea; with or without
             wheezing; relief spontaneously or after using bronchodilators; FEV1/FVC&lt;0.70,with
             positive bronchial reversible test.

          3. Asthma combined with COPD (ACOS) patients: patients with ACOS are included in asthma
             group.

          4. Healthy volunteers: No smoking history, or have quit smoking at least 5 years. Chest
             X-ray show no abnormality.

          5. Information consent form should be signed before entering the study.

        Exclusion Criteria:

          1. The latest severe acute attack occurred within 4 weeks:

               1. Severe acute attack: status asthmaticus or acute exacerbation of COPD leading to
                  consultation, emergency treatment，hospitalization, or glucocorticoid
                  treatment（oral/i.v).

               2. Controllable non-hospitalized acute attack without glucocorticoid
                  treatment(oral/i.v). COPD attack lasting less than 48h or asthma attack lasting
                  less than 24h are not excluded.

          2. Any history of acute/chronic respiratory diseases other than asthma and COPD,
             including lung cancer and pulmonary infection.

          3. Plasma ALT or AST greater than 2 times of the upper normal limit; plasma Creatinine
             greater than 1.5 times of the upper normal limit.

          4. Left heart insufficiency, or malignant arrhythmia.

          5. HIV positive.

          6. Acute cerebrovascular events within 3 months, including apoplexy, transient cerebral
             ischemia and acute coronary syndrome.

          7. Uncured malignant tumors.

          8. Addicted to drug or alcohol, or any history of psychiatric disorders.

          9. Breastfeeding, pregnancy or planning to be pregnant.

         10. Estimated lifetime less than 2 years due to underlying diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kai-Feng Xu, M.D.</last_name>
    <phone>86-10-69155039</phone>
    <email>xukf@pumch.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xinlun Tian, M.D.</last_name>
    <phone>86-10-69155039</phone>
    <email>tianxl@pumch.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai-Feng Xu, M.D.</last_name>
      <phone>86-10-69155039</phone>
      <email>xukf@pumch.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xinlun Tian, M.D.</last_name>
      <phone>86-10-69155039</phone>
      <email>xinlun_t@sina.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xinlun Tian, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kai-Feng Xu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2017</study_first_submitted>
  <study_first_submitted_qc>June 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2017</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary function</keyword>
  <keyword>Particulate matter</keyword>
  <keyword>COPD</keyword>
  <keyword>Asthma</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

